In this review, we summarize the available data on the dual role of Smad7, also known as mothers against decapentaplegic homolog 7 (MADH7), in colonic carcinogenesis, and discuss potential advantages and drawbacks in targeting such a molecule in CRC patients. This evidence concerns the gene SMAD7 and colorectal carcinoma.